From the Editor - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

From the Editor

Truth and Transparency

June 2, 2009

Pharmaceutical Technology

Misleading the public about their investments—be it money or medicine—is unacceptable.

Parallel Tracks

April 2, 2009

Pharmaceutical Technology

Obama's cost-containment and science-innovation initiatives need to overlap.

Whither FDA?

February 2, 2009

Pharmaceutical Technology

FDA's role should not be overlooked as it has been in years past.

A New Start for New Cells

January 2, 2009

Pharmaceutical Technology

The incoming administration has renewed hope for stem cells, but less adequate copycats may follow.

A Tale of Two Pharmaceutical Industries

December 2, 2008

Pharmaceutical Technology

China's quality approach to domestic versus exported products seems to be a lose-lose situation.

Quality Counts

November 2, 2008

Pharmaceutical Technology

Pharma companies could benefit from the lessons learned in this fall's financial crisis.

The Past as Prologue

October 2, 2008

Pharmaceutical Technology

Can previous trends of Democratic and Republican administrations predict industry's future?

Dirty Hands

September 2, 2008

Pharmaceutical Technology

Are hypersanitation trends a result of scaremongering or a lack of faith in medicine?

FDA and Medicare at Odds?

August 2, 2008

Pharmaceutical Technology

Legislative decisions to increase Medicare's formulary may lead to a fight over drug approvals.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
31%
Breakthrough designations
15%
Protecting the supply chain
46%
Expedited reviews of drug submissions
8%
More stakeholder involvement
0%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Click here